Pathogenic function of IL-1β in psoriasiform skin lesions of flaky skin (fsn/fsn) mice

Clinical and Experimental Immunology

Volumn 123, Issue 3, 2001, Pages 505-510

  Schon M ^a,c   Behmenburg, C ^a   Denzer, D ^a,b   Schon M P ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BAYER AG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cytokines IL 1 psoriasis; Flaky skin inflammation

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNOREGULATION; LANGERHANS CELL; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SKIN ABSCESS; SKINFOLD THICKNESS; T LYMPHOCYTE;

ANIMALS; INTERLEUKIN-1; MICE; MICE, MUTANT STRAINS; NEUTRALIZATION TESTS; PSORIASIS; SKIN;

EID: 0035073459     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01421.x     Document Type: Article

References (31)

1. Psoriasis
2. The cytokine network of psoriasis
3. Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor
4. Interleukin-1 and interleukin-6 in psoriasis
5. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response
6. Detection of inflammatory cytokines in psoriatic skin
7. The IL-1 system in psoriatic skin. IL-1 antagonist sphere of influence in lesional psoriatic epidermis
8. IL-1 activity is reduced in psoriatic skin: Decreased IL-1α and increased nonfunctional IL-1β
9. Interleukin-1 in human skin: Dysregulation in psoriasis
10. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: Interleukin-6 involved in formation of psoriatic lesions
11. In situ hybridization analysis of cytokine, proto-oncogene and tumor suppressor gene expression in psoriasis
12. Enhanced production of biologically active interleukin-1α and interleukin-1β by psoriatic epidermal cells ex vivo: Evidence of increased cytosolic interleukin-1β levels and facilitated interleukin-1 release
13. Biologically active, alternatively processed interleukin-1β in psoriatic scales
14. Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris
15. Mast cells and macrophages in early relapsing psoriasis
16. Mast cell alterations in chronic psoriasis vulgaris; Response to low-strength anthralin treatment. A transmission electron microscopic study
17. Rapid and specific conversion of precursor inteleukin-1β (IL-1β) to an active IL-1 species by human mast cell chymase
18. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis
19. The flaky skin (fsn) mutation in mice: Map location and description of the anemia
20. The flaky skin (fsn) mutation, chromosme?
21. Lymphadenopathy, elevated serum IgE levels, autoimmunity, and mast cell accumulation in flaky skin mutant mice
22. Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses
23. Animal models of psoriasis - What can we learn from them?
24. Critical role of neutrophils for the generation of psoriasis skin lesions in flaky skin mice
25. Cytochemical identification of monocytes and granulocytes
26. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis
27. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human b2m: An animal model of HLA-B27-associated human disorders
28. Murine psoriasis-like disorder induced by naive CD4+ T-cells
29. Epidermal dendritic cell populations in the flaky skin mouse mutant
30. The SCID mouse mutant: Definition, characterization, and potential uses
31. Increased epidermal growth factor receptor in fsn.fsn mice